SPONSOR
Adverum Biotechnologies, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 3
Adverum Biotechnologies, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Adverum Biotechnologies, Inc.
How many clinical trials has Adverum Biotechnologies, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Adverum Biotechnologies, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Adverum Biotechnologies, Inc. research focus on?
Adverum Biotechnologies, Inc. clinical trials span Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Adverum Biotechnologies, Inc. clinical trial?
To participate in a Adverum Biotechnologies, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Adverum Biotechnologies, Inc. trials with current recruitment status updated daily.
Clinical Trials by Adverum Biotechnologies, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology